What You Should Know:
- MedAdvisor Solutions and Brand Engagement Network (BEN) today announced the launch of their AI-driven medication advisor.
- This innovative solution is designed to enhance patient engagement, reduce pharmacist workload, and improve medication adherence.
AI-driven Medication Advisor
The medication advisor will be showcased at the upcoming National Association of Chain Drug Stores (NACDS) Total Store Expo, where attendees can interact with a
Read More
New Survey Sheds Light on How Physicians Experience Interoperability
What You Should Know:
- A collaborative effort between the Assistant Secretary for Technology Policy and Office of the National Coordinator for Health IT (ASTP), the American Board of Family Medicine (ABFM), and the University of California, San Francisco (UCSF) has yielded significant insights into the challenges and opportunities of health IT interoperability in primary care.
- By embedding HIT-related questions into the ABFM’s Continuous Certification Questionnaire (CCQ),
Read More
Sheba Medical Center Develops AI Algorithm to Predict Pulmonary Embolism
What You Should Know:
- Sheba Medical Center, a globally recognized healthcare leader, announced the publication of a groundbreaking study demonstrating the effectiveness of an AI algorithm in predicting pulmonary embolism (PE) risk upon hospital admission.
- The research, published in the Journal of Medical Internet Research, involved analyzing medical records of over 46,000 patients and identifying a machine learning model capable of accurately predicting PE
Read More
Luminopia’s Amblyopia Treatment Gains Coverage from Highmark
What You Should Know:
- Luminopia, a digital health company focused on treating neuro-visual disorders, announced today that Highmark has approved coverage for its FDA-cleared therapy for children with amblyopia.
- This decision marks a significant milestone for Luminopia, as it expands access to its innovative treatment for a condition that affects millions of children.
What is Amblyopia?
Amblyopia, commonly known as lazy eye, is a leading cause of vision loss in
Read More
FuturHealth Combines GLP-1 Medications with Personalized Nutrition
What You Should Know:
- FuturHealth, a leader in personalized weight-loss solutions launches its Custom Meal Plans. Designed to complement the growing popularity of GLP-1 medications, the new offering provides a comprehensive approach to weight management and long-term health.
- As the use of GLP-1 medications surges, FuturHealth recognizes the need for a holistic approach to weight loss. By combining personalized meal plans with medication, FuturHealth aims to help individuals
Read More
Abbott and Medtronic Partner to Integrate CGM System & Insulin Delivery Devices
What You Should Know:
- Abbott and Medtronic announced a groundbreaking partnership to develop an integrated continuous glucose monitoring (CGM) system designed to seamlessly work with Medtronic’s automated insulin delivery (AID) and smart insulin pen systems.
- The strategic collaboration aims to improve diabetes management by enabling more precise insulin dosing and reducing the burden on patients.
CGM System and Insulin Delivery Devices Integration
The new CGM sensor,
Read More
Patients Demand Personalized Obesity Care, New Survey Finds
What You Should Know:
- Phenomix Sciences, a precision medicine biotechnology company, released findings from a new survey revealing a growing demand for personalized obesity care.
- The survey of 475 patients explored attitudes toward weight management, treatment preferences, and information sources.
Key Findings:
Patients Seek Medical Guidance: A majority of respondents (66%) prefer guidance from healthcare providers to manage weight loss, highlighting the need for a
Read More
Physicians Reveals GLP-1s for Weight Loss are Overprescribed and Unsustainable
What You Should Know:
- A large majority of physicians feel GLP-1s are being overprescribed, according to a new survey from Virta Health, a leader in type 2 diabetes reversal.
- The Virta Health survey was conducted in partnership with Beresford Research and included 300 primary care providers, endocrinologists, and obesity specialists across the United States sheds light on the medical community's views on the rapidly growing class of GLP-1 medications, often hailed as
Read More
FemTech: Fertilitywise Partners with Fairfax EggBank to Empower Patients
What You Should Know:
- Fertilitywise, a provider of resources and support for those navigating fertility challenges, announced a new partnership with Fairfax EggBank, a prominent donor egg program. This collaboration aims to enhance the fertility journey for patients by offering comprehensive support and information.
- Through this partnership, Fairfax EggBank patients will receive a complimentary two-month membership to Fertilitywise, providing access to a wealth of evidence-based
Read More
venBio Raises $528M for Fifth Life Sciences Fund
What You Should Know:
- venBio, a leading life sciences venture capital firm, announced the successful closing of its fifth fund, venBio Fund V, with over $528M in capital commitments.
- The new fund will focus on investing in biopharmaceutical companies developing innovative treatments for unmet medical needs.
venBio Fund V Focus
With a strong track record of successful investments in companies such as Labrys Biologics, Aragon Pharmaceuticals, and Seragon
Read More
